Diseases

Explore disease pages that summarize symptoms, diagnostic context, and related care topics.

Featured: 100

Browse A-Z

Page 42 of 84

Diseases starting with P (8,390)

T451X3D

Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter

T451X2A

Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter

T451X2S

Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela

T451X2D

Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter

T451X4A

Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter

T451X4S

Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela

T451X4D

Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter

T428X1A

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), initial encounter

T428X1S

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), sequela

T428X1D

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), subsequent encounter

T428X3A

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, initial encounter

T428X3S

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, sequela

T428X3D

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, subsequent encounter

T428X2A

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, initial encounter

T428X2S

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, sequela

T428X2D

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, subsequent encounter

T428X4A

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, initial encounter

T428X4S

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, sequela

T428X4D

Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, subsequent encounter

T491X1A

Poisoning by antipruritics, accidental (unintentional), initial encounter

T491X1S

Poisoning by antipruritics, accidental (unintentional), sequela

T491X1D

Poisoning by antipruritics, accidental (unintentional), subsequent encounter

T491X3A

Poisoning by antipruritics, assault, initial encounter

T491X3S

Poisoning by antipruritics, assault, sequela

T491X3D

Poisoning by antipruritics, assault, subsequent encounter

T491X2A

Poisoning by antipruritics, intentional self-harm, initial encounter

T491X2S

Poisoning by antipruritics, intentional self-harm, sequela

T491X2D

Poisoning by antipruritics, intentional self-harm, subsequent encounter

T491X4A

Poisoning by antipruritics, undetermined, initial encounter

T491X4S

Poisoning by antipruritics, undetermined, sequela

T491X4D

Poisoning by antipruritics, undetermined, subsequent encounter

T394X1A

Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter

T394X1S

Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), sequela

T394X1D

Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), subsequent encounter

T394X3A

Poisoning by antirheumatics, not elsewhere classified, assault, initial encounter

T394X3S

Poisoning by antirheumatics, not elsewhere classified, assault, sequela

T394X3D

Poisoning by antirheumatics, not elsewhere classified, assault, subsequent encounter

T394X2A

Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter

T394X2S

Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, sequela

T394X2D

Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, subsequent encounter

T394X4A

Poisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter

T394X4S

Poisoning by antirheumatics, not elsewhere classified, undetermined, sequela

T394X4D

Poisoning by antirheumatics, not elsewhere classified, undetermined, subsequent encounter

T45521A

Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter

T45521S

Poisoning by antithrombotic drugs, accidental (unintentional), sequela

T45521D

Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter

T45523A

Poisoning by antithrombotic drugs, assault, initial encounter

T45523S

Poisoning by antithrombotic drugs, assault, sequela

T45523D

Poisoning by antithrombotic drugs, assault, subsequent encounter

T45522A

Poisoning by antithrombotic drugs, intentional self-harm, initial encounter

T45522S

Poisoning by antithrombotic drugs, intentional self-harm, sequela

T45522D

Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter

T45524A

Poisoning by antithrombotic drugs, undetermined, initial encounter

T45524S

Poisoning by antithrombotic drugs, undetermined, sequela

T45524D

Poisoning by antithrombotic drugs, undetermined, subsequent encounter

T382X1A

Poisoning by antithyroid drugs, accidental (unintentional), initial encounter

T382X1S

Poisoning by antithyroid drugs, accidental (unintentional), sequela

T382X1D

Poisoning by antithyroid drugs, accidental (unintentional), subsequent encounter

T382X3A

Poisoning by antithyroid drugs, assault, initial encounter

T382X3S

Poisoning by antithyroid drugs, assault, sequela

T382X3D

Poisoning by antithyroid drugs, assault, subsequent encounter

T382X2A

Poisoning by antithyroid drugs, intentional self-harm, initial encounter

T382X2S

Poisoning by antithyroid drugs, intentional self-harm, sequela

T382X2D

Poisoning by antithyroid drugs, intentional self-harm, subsequent encounter

T382X4A

Poisoning by antithyroid drugs, undetermined, initial encounter

T382X4S

Poisoning by antithyroid drugs, undetermined, sequela

T382X4D

Poisoning by antithyroid drugs, undetermined, subsequent encounter

T483X1A

Poisoning by antitussives, accidental (unintentional), initial encounter

T483X1S

Poisoning by antitussives, accidental (unintentional), sequela

T483X1D

Poisoning by antitussives, accidental (unintentional), subsequent encounter

T483X3A

Poisoning by antitussives, assault, initial encounter

T483X3S

Poisoning by antitussives, assault, sequela

T483X3D

Poisoning by antitussives, assault, subsequent encounter

T483X2A

Poisoning by antitussives, intentional self-harm, initial encounter

T483X2S

Poisoning by antitussives, intentional self-harm, sequela

T483X2D

Poisoning by antitussives, intentional self-harm, subsequent encounter

T483X4A

Poisoning by antitussives, undetermined, initial encounter

T483X4S

Poisoning by antitussives, undetermined, sequela

T483X4D

Poisoning by antitussives, undetermined, subsequent encounter

T468X1A

Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter

T468X1S

Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela

T468X1D

Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter

T468X3A

Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter

T468X3S

Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela

T468X3D

Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter

T468X2A

Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter

T468X2S

Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela

T468X2D

Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter

T468X4A

Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter

T468X4S

Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela

T468X4D

Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter

T375X1A

Poisoning by antiviral drugs, accidental (unintentional), initial encounter

T375X1S

Poisoning by antiviral drugs, accidental (unintentional), sequela

T375X1D

Poisoning by antiviral drugs, accidental (unintentional), subsequent encounter

T375X3A

Poisoning by antiviral drugs, assault, initial encounter

T375X3S

Poisoning by antiviral drugs, assault, sequela

T375X3D

Poisoning by antiviral drugs, assault, subsequent encounter

T375X2A

Poisoning by antiviral drugs, intentional self-harm, initial encounter

T375X2S

Poisoning by antiviral drugs, intentional self-harm, sequela

T375X2D

Poisoning by antiviral drugs, intentional self-harm, subsequent encounter